seekingalpha.com/news/...nt-premarket-pricing-equity-offering
"..Phio Pharmaceuticals (NASDAQ:PHIO) prices its public offering of 10M common shares at $0.10/share, for gross proceeds of $1M.
Net proceeds will be used to fund the development of its immuno-oncology programs, for other R&D activities and for general working capital needs.
Closing date is November 19..."